4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-21-031337
Chief Scientific Officer sold 150,000 shares at $22.75 ($3,412,500)
From the SEC's structured data for this filing
Trades in this filing
Leen Ann M. · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-10 | Sale : show line 1 in the form | −150,000 | $22.75 | $3,412,500 | 2,309,142 | I |
| Open-market sales · 150,000 sh · avg $22.75 · $3,412,500 | ||||||
Loading xslF345X03/doc4.xml…